DaVita HealthCare Partners Inc. (DVA) Shares Gap Up to $63.60
DaVita HealthCare Partners Inc. (NYSE:DVA)’s share price gapped up prior to trading on Tuesday . The stock had previously closed at $63.51, but opened at $63.60. DaVita HealthCare Partners shares last traded at $65.01, with a volume of 893,059 shares trading hands.
DVA has been the subject of several recent analyst reports. Bank of America Corp. lowered DaVita HealthCare Partners from a “buy” rating to a “neutral” rating and set a $70.00 price target for the company. in a research note on Tuesday, September 6th. Citigroup Inc. initiated coverage on DaVita HealthCare Partners in a research note on Tuesday, September 6th. They set a “neutral” rating and a $71.00 price objective for the company. JPMorgan Chase & Co. boosted their price objective on DaVita HealthCare Partners from $74.00 to $75.00 and gave the stock a “neutral” rating in a research note on Tuesday, August 9th. Zacks Investment Research lowered DaVita HealthCare Partners from a “hold” rating to a “sell” rating in a research note on Monday, July 18th. Finally, TheStreet lowered DaVita HealthCare Partners from a “buy” rating to a “hold” rating in a research note on Monday, August 8th. One analyst has rated the stock with a sell rating, eight have issued a hold rating and six have issued a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus target price of $76.36.
The stock has a market cap of $13.45 billion, a P/E ratio of 37.81 and a beta of 1.07. The company has a 50-day moving average price of $67.12 and a 200-day moving average price of $73.18.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/20/davita-healthcare-partners-inc-dva-shares-gap-up-to-63-60.html
DaVita HealthCare Partners (NYSE:DVA) last issued its quarterly earnings data on Monday, August 8th. The company reported $1.01 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.98 by $0.03. DaVita HealthCare Partners had a net margin of 2.51% and a return on equity of 16.48%. The business earned $3.72 billion during the quarter, compared to analysts’ expectations of $3.67 billion. During the same period last year, the company posted $0.95 EPS. The company’s revenue was up 8.2% on a year-over-year basis. On average, equities analysts predict that DaVita HealthCare Partners Inc. will post $3.76 EPS for the current fiscal year.
In other DaVita HealthCare Partners news, COO Michael David Staffieri sold 20,262 shares of DaVita HealthCare Partners stock in a transaction that occurred on Tuesday, August 9th. The shares were sold at an average price of $73.09, for a total value of $1,480,949.58. Following the completion of the sale, the chief operating officer now directly owns 52,279 shares of the company’s stock, valued at approximately $3,821,072.11. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Jeanine Marie Jiganti sold 4,620 shares of DaVita HealthCare Partners stock in a transaction that occurred on Friday, July 1st. The stock was sold at an average price of $77.45, for a total transaction of $357,819.00. Following the completion of the sale, the insider now directly owns 7,590 shares of the company’s stock, valued at $587,845.50. The disclosure for this sale can be found here. Insiders own 2.10% of the company’s stock.
A number of hedge funds have recently added to or reduced their stakes in DVA. Norges Bank purchased a new stake in DaVita HealthCare Partners during the fourth quarter valued at approximately $135,225,000. BlackRock Group LTD boosted its stake in DaVita HealthCare Partners by 30.8% in the first quarter. BlackRock Group LTD now owns 2,388,453 shares of the company’s stock valued at $175,265,000 after buying an additional 562,907 shares during the last quarter. Riverhead Capital Management LLC boosted its stake in DaVita HealthCare Partners by 262.9% in the second quarter. Riverhead Capital Management LLC now owns 512,529 shares of the company’s stock valued at $18,670,000 after buying an additional 371,289 shares during the last quarter. Locust Wood Capital Advisers LLC purchased a new stake in DaVita HealthCare Partners during the second quarter valued at approximately $25,214,000. Finally, BlackRock Fund Advisors boosted its stake in DaVita HealthCare Partners by 7.5% in the first quarter. BlackRock Fund Advisors now owns 4,206,870 shares of the company’s stock valued at $308,700,000 after buying an additional 293,323 shares during the last quarter. 83.65% of the stock is owned by hedge funds and other institutional investors.
About DaVita HealthCare Partners
DaVita HealthCare Partners Inc is a provider of kidney care services. The Company operates Kidney Care division and HealthCare Partners (HCP) division. Its segments include U.S. dialysis and related lab services, HCP and Other-Ancillary services and strategic initiatives. Its Kidney Care division is a provider of dialysis services in the United States, treating patients with chronic kidney failure and end stage renal disease (ESRD).
Receive News & Ratings for DaVita HealthCare Partners Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita HealthCare Partners Inc. and related companies with MarketBeat.com's FREE daily email newsletter.